The Holy Grail of stem cell therapy is pluripotent stem cells. Those are the ones that can turn into ANY cell type in the whole body and would be fantastic if they were available clinically!
In this video, R3 Stem Cell Founder/CEO David Greene MD, PhD, MBA explains induced pluripotent stem cells, known for short as iPSC's. The inventor of them received a Nobel prize at the time, as they avoid any ethical issues involving aborted fetuses. Are they clinically available? Watch to find out.
R3 Stem Cell is the world's largest provider of regenerative therapies, with over 28,000 stem cell procedures in the past decade. R3 has an 85% patient satisfaction rate and has clinics in 8 countries. This includes USA, Mexico, Pakistan, India, South Africa, Turkey, Philippines and UAE.
Comments